Denali Therapeutics IncNASDAQ:DNLI
- LAST PRICE20.7700
- TODAY'S CHANGE (%)-0.5400 (-2.5340%)
- Bid / Lots20.7800/ 1
- Ask / Lots22.6200/ 1
- Open / Previous Close20.8200 / 21.3100
- Day Range
- 52 Week Range
- Volume792,584
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNLI |
|---|---|---|
| 09:32 ET | 10141 | 20.85 |
| 09:34 ET | 1500 | 20.815 |
| 09:36 ET | 644 | 20.685 |
| 09:38 ET | 528 | 20.705 |
| 09:39 ET | 200 | 20.68 |
| 09:41 ET | 400 | 20.7 |
| 09:43 ET | 1439 | 20.76 |
| 09:45 ET | 460 | 20.68 |
| 09:48 ET | 513 | 20.65 |
| 09:50 ET | 100 | 20.65 |
| 09:52 ET | 218 | 20.73 |
| 09:54 ET | 2139 | 20.62 |
| 09:56 ET | 2447 | 20.52 |
| 09:57 ET | 1605 | 20.48 |
| 09:59 ET | 13189 | 20.51 |
| 10:01 ET | 1396 | 20.415 |
| 10:03 ET | 2146 | 20.55 |
| 10:06 ET | 4277 | 20.65 |
| 10:08 ET | 1543 | 20.68 |
| 10:10 ET | 642 | 20.68 |
| 10:12 ET | 1315 | 20.765 |
| 10:14 ET | 1231 | 20.73 |
| 10:15 ET | 1673 | 20.79 |
| 10:17 ET | 812 | 20.78 |
| 10:19 ET | 2075 | 20.75 |
| 10:21 ET | 721 | 20.82 |
| 10:24 ET | 2052 | 20.87 |
| 10:26 ET | 1029 | 20.85 |
| 10:28 ET | 1033 | 20.78 |
| 10:30 ET | 787 | 20.73 |
| 10:32 ET | 1943 | 20.78 |
| 10:33 ET | 1150 | 20.795 |
| 10:37 ET | 1619 | 20.79 |
| 10:39 ET | 400 | 20.825 |
| 10:42 ET | 1988 | 20.86 |
| 10:44 ET | 400 | 20.85 |
| 10:48 ET | 300 | 20.85 |
| 10:50 ET | 1027 | 20.88 |
| 10:51 ET | 2127 | 20.92 |
| 10:53 ET | 600 | 20.845 |
| 10:55 ET | 327 | 20.8 |
| 10:57 ET | 900 | 20.83 |
| 11:00 ET | 400 | 20.85 |
| 11:02 ET | 700 | 20.835 |
| 11:04 ET | 500 | 20.855 |
| 11:06 ET | 615 | 20.86 |
| 11:08 ET | 1296 | 20.83 |
| 11:09 ET | 200 | 20.855 |
| 11:11 ET | 300 | 20.85 |
| 11:13 ET | 300 | 20.86 |
| 11:15 ET | 1206 | 20.9 |
| 11:18 ET | 400 | 20.89 |
| 11:20 ET | 1737 | 20.875 |
| 11:22 ET | 2800 | 20.85 |
| 11:24 ET | 2000 | 20.9 |
| 11:26 ET | 100 | 20.975 |
| 11:27 ET | 200 | 20.98 |
| 11:29 ET | 1169 | 20.92 |
| 11:31 ET | 300 | 20.93 |
| 11:33 ET | 400 | 20.93 |
| 11:36 ET | 500 | 20.935 |
| 11:38 ET | 500 | 20.9 |
| 11:40 ET | 2000 | 20.91 |
| 11:42 ET | 1500 | 20.95 |
| 11:44 ET | 250 | 20.9001 |
| 11:49 ET | 300 | 20.895 |
| 11:51 ET | 1225 | 20.87 |
| 11:54 ET | 100 | 20.85 |
| 11:56 ET | 357 | 20.83 |
| 11:58 ET | 418 | 20.85 |
| 12:00 ET | 300 | 20.835 |
| 12:02 ET | 800 | 20.81 |
| 12:03 ET | 2457 | 20.875 |
| 12:05 ET | 1532 | 20.85 |
| 12:07 ET | 660 | 20.865 |
| 12:09 ET | 2014 | 20.91 |
| 12:12 ET | 400 | 20.92 |
| 12:14 ET | 300 | 20.9 |
| 12:16 ET | 400 | 20.88 |
| 12:18 ET | 913 | 20.8856 |
| 12:20 ET | 400 | 20.875 |
| 12:21 ET | 1888 | 20.91 |
| 12:23 ET | 300 | 20.89 |
| 12:25 ET | 1470 | 20.86 |
| 12:27 ET | 200 | 20.8625 |
| 12:30 ET | 400 | 20.855 |
| 12:32 ET | 400 | 20.86 |
| 12:34 ET | 600 | 20.81 |
| 12:36 ET | 500 | 20.82 |
| 12:38 ET | 526 | 20.79 |
| 12:39 ET | 200 | 20.78 |
| 12:41 ET | 300 | 20.79 |
| 12:43 ET | 400 | 20.78 |
| 12:45 ET | 1000 | 20.86 |
| 12:50 ET | 500 | 20.845 |
| 12:52 ET | 715 | 20.88 |
| 12:54 ET | 1324 | 20.88 |
| 12:56 ET | 935 | 20.88 |
| 12:57 ET | 2379 | 20.905 |
| 12:59 ET | 647 | 20.91 |
| 01:01 ET | 653 | 20.86 |
| 01:03 ET | 1593 | 20.87 |
| 01:06 ET | 500 | 20.86 |
| 01:08 ET | 2194 | 20.89 |
| 01:10 ET | 641 | 20.9 |
| 01:12 ET | 2937 | 20.895 |
| 01:14 ET | 189 | 20.93 |
| 01:17 ET | 1900 | 20.91 |
| 01:19 ET | 256 | 20.91 |
| 01:21 ET | 1212 | 20.94 |
| 01:24 ET | 400 | 20.93 |
| 01:26 ET | 1511 | 20.9 |
| 01:28 ET | 1514 | 20.89 |
| 01:30 ET | 1959 | 20.88 |
| 01:32 ET | 500 | 20.85 |
| 01:33 ET | 200 | 20.845 |
| 01:35 ET | 300 | 20.83 |
| 01:37 ET | 524 | 20.85 |
| 01:39 ET | 1351 | 20.865 |
| 01:42 ET | 899 | 20.835 |
| 01:44 ET | 100 | 20.83 |
| 01:46 ET | 307 | 20.84 |
| 01:48 ET | 100 | 20.83 |
| 01:50 ET | 100 | 20.82 |
| 01:51 ET | 600 | 20.8 |
| 01:53 ET | 622 | 20.8 |
| 01:55 ET | 400 | 20.795 |
| 01:57 ET | 400 | 20.8 |
| 02:00 ET | 440 | 20.78 |
| 02:02 ET | 3112 | 20.775 |
| 02:04 ET | 1176 | 20.765 |
| 02:06 ET | 1167 | 20.73 |
| 02:08 ET | 1681 | 20.75 |
| 02:09 ET | 1550 | 20.74 |
| 02:11 ET | 1200 | 20.78 |
| 02:13 ET | 3040 | 20.74 |
| 02:15 ET | 1773 | 20.73 |
| 02:18 ET | 1723 | 20.76 |
| 02:20 ET | 100 | 20.755 |
| 02:22 ET | 500 | 20.78 |
| 02:24 ET | 400 | 20.76 |
| 02:26 ET | 400 | 20.765 |
| 02:27 ET | 100 | 20.765 |
| 02:29 ET | 1801 | 20.78 |
| 02:31 ET | 300 | 20.76 |
| 02:33 ET | 938 | 20.795 |
| 02:36 ET | 329 | 20.785 |
| 02:38 ET | 693 | 20.79 |
| 02:40 ET | 100 | 20.79 |
| 02:42 ET | 300 | 20.78 |
| 02:44 ET | 100 | 20.78 |
| 02:45 ET | 1947 | 20.795 |
| 02:47 ET | 500 | 20.795 |
| 02:51 ET | 800 | 20.76 |
| 02:54 ET | 100 | 20.755 |
| 02:56 ET | 2036 | 20.76 |
| 02:58 ET | 327 | 20.74 |
| 03:00 ET | 100 | 20.705 |
| 03:02 ET | 1200 | 20.69 |
| 03:05 ET | 1200 | 20.75 |
| 03:07 ET | 1000 | 20.76 |
| 03:09 ET | 800 | 20.725 |
| 03:12 ET | 1071 | 20.7 |
| 03:14 ET | 1620 | 20.7 |
| 03:16 ET | 1317 | 20.73 |
| 03:18 ET | 300 | 20.73 |
| 03:20 ET | 1400 | 20.71 |
| 03:21 ET | 600 | 20.69 |
| 03:23 ET | 200 | 20.7 |
| 03:25 ET | 1329 | 20.73 |
| 03:27 ET | 3496 | 20.74 |
| 03:30 ET | 1000 | 20.67 |
| 03:32 ET | 3200 | 20.66 |
| 03:34 ET | 4325 | 20.65 |
| 03:36 ET | 1601 | 20.68 |
| 03:38 ET | 100 | 20.69 |
| 03:39 ET | 100 | 20.68 |
| 03:41 ET | 2168 | 20.635 |
| 03:43 ET | 600 | 20.63 |
| 03:45 ET | 1725 | 20.62 |
| 03:48 ET | 4498 | 20.635 |
| 03:50 ET | 1600 | 20.68 |
| 03:52 ET | 3957 | 20.73 |
| 03:54 ET | 3000 | 20.69 |
| 03:56 ET | 11001 | 20.65 |
| 03:57 ET | 7374 | 20.64 |
| 03:59 ET | 130812 | 20.77 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Denali Therapeutics Inc | 2.9B | -21.5x | --- |
Genmab A/S | 18.7B | 23.0x | +22.71% |
MorphoSys AG | 2.8B | -5.3x | --- |
Amicus Therapeutics Inc | 3.0B | -20.4x | --- |
Twist Bioscience Corp | 2.7B | -15.1x | --- |
Arrowhead Pharmaceuticals Inc | 3.1B | -5.6x | --- |
Company Information
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Contact Information
- Headquarters
- 161 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1910
- Phone
- 650-866-8548
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Vicki Sato
- President, Chief Executive Officer, Director
- Ryan Watts
- Chief Financial Officer, Chief Operating Officer, Company Secretary
- Alexander Schuth
- Chief Medical Officer
- Carole Ho
- Director
- Steven Krognes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $295.4M |
Shares Outstanding | 142.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-0.97 |
Book Value | $7.45 |
P/E Ratio | -21.5x |
Price/Sales (TTM) | 10.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -65.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
